Retatrutide (15MG)

Description

Triple Agonist Research Peptide for Advanced Metabolic Studies

What is Retatrutide?

Retatrutide is a novel triple agonist peptide that activates GIP, GLP-1, and glucagon receptors simultaneously. This represents next-generation metabolic research beyond dual agonists like Tirzepatide, with studies showing significant potential in weight management and metabolic health research.

Research Overview: As a tri-agonist, Retatrutide has been studied for its multifaceted approach to metabolic regulation—combining appetite suppression pathways, enhanced insulin sensitivity, and increased energy expenditure in laboratory settings. Research data suggests it may offer superior efficacy compared to single or dual agonist compounds.

Research Areas of Interest

🔹 Advanced Weight Management Research

• Triple-pathway metabolic activation
• Appetite regulation mechanisms
• Body composition studies
• Superior weight reduction in clinical trials

🔹 Metabolic Health Studies

• Blood glucose regulation pathways
• Insulin sensitivity research
• Lipid metabolism investigations
• Energy expenditure mechanisms

🔹 Cardiovascular Research

• Metabolic cardiovascular benefits
• Blood pressure regulation studies
• Cardiovascular risk marker reduction

🔹 Body Composition Research

• Fat mass reduction studies
• Lean mass preservation
• Visceral fat targeting

Product Specifications

• Dose: 10mg per vial
• Purity: 99%+
• Form: Lyophilized powder
• Storage: Refrigerate after reconstitution
• Shelf Life: 2 years (powder), 30 days (reconstituted)

Why Choose Our Retatrutide?

✓ Third-party tested for purity and potency
✓ Pharmaceutical-grade manufacturing
✓ Fast Australian shipping
✓ Discreet packaging
✓ Certificate of analysis available upon request

IMPORTANT NOTICE

This product is sold strictly for research purposes only. It is not intended for human consumption, and is not intended to diagnose, treat, cure, or prevent any disease. This product has not been evaluated by the TGA or FDA. Buyers must be 18+ and acknowledge this is a research compound only.